So, with her transactional background -- and an org chart role reporting directly to CEO Dick Clark -- AND CEO Clark's repeated public commentary to the effect that [legacy Schering-Plough] Consumer Health. . . will need a partner, is the handwriting on the wall for a spinoff, splitoff, sale, joint venture or other transaction related to these Merck businesses?